Results 81 to 90 of about 27,990 (252)
Cytomegalovirus-Related Immune Thrombocytopenic Purpura in an Immunocompetent Adult
We present the case of a 42-year-old immunocompetent man who was diagnosed with acute immune thrombocytopenic purpura and had evidence of an acute cytomegalovirus infection, concerning for secondary immune thrombocytopenic purpura.
Derek J. Essegian, Rachel A. Sibley
doaj +1 more source
Immune Thrombocytopenic Purpura of Childhood
Abstract Immune mediated thrombocytopenia (ITP) is a common manifestation of autoimmune disease in children. Although patients often present with bruises, petechiae, and some mucosal bleeding, the incidence of life-threatening hemorrhage is rare (0.2–0.9%) but can be fatal when presenting in vital organs.
openaire +3 more sources
The use of rituximab as a pre‐emptive treatment in immune‐mediated thrombotic thrombocytopenic purpura (iTTP) is the current standard of care. However, for patients refractory to rituximab or for those with contraindication, further treatment guidelines are scarce.
Julia Weisinger+4 more
wiley +1 more source
A case of refractory thrombotic thrombocytopenic purpura treated with plasmapheresis and rituximab [PDF]
Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disorder with no prevalence or incidence studies in sub-Saharan Africa. Acquired TTP has several causes, all of which lead to decreased activity of von Willebrand factor cleaving ...
Kirui, Nicholas, Sokwala, Ahmed
core +4 more sources
Prevalence of Immune Thrombocytopenia Purpura in Wasit Province
A lower than normal platelet count is a hallmark of the acquired autoimmune disease immune thrombocytopenic purpura (ITP). This autoimmune disease is characterized by low platelet counts, purpura, and hemorrhagic episodes caused by antiplatelet ...
Rawan Alaa
doaj +1 more source
Thrombotic thrombocytopenic purpura [PDF]
Thrombotic thrombocytopenic purpura (TTP) is a disease with a high rate of mortality if a proper treatment is not instated. Plasmapheresis with plasmatic exchange is the treatment of choice. Diagnosis is performed demonstrating microangiopathic hemolytic
Gómez Almaguer, David+2 more
core +1 more source
Objective: To assess reticulin fibrosis in benign hematologic disorders and to understand the impact of benign hematologic disorders on the immune system. Study Design: Cross-sectional study.
Yasir Shabbir+5 more
doaj +1 more source
Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia [PDF]
Immune thrombocytopenia (ITP) is characterised by a transient or persistent decrease in platelets accompanied by an increased risk of bleeding, which can have a significant negative impact on patients' health-related quality of life.
Imbach, Paul, Kühne, Thomas
core
Worku Ketema,1 Kefyalew Taye,1 Negash Tagesse,1 Aberash Eifa2 1Department of Paediatrics and Child Health, Hawassa University Comprehensive Specialized Hospital, Hawassa, Ethiopia; 2Department of Midwifery, Hawassa University Comprehensive Specialized ...
Ketema W, Taye K, Tagesse N, Eifa A
doaj